Evidence map›Paper›PMID 32368697›Full record

ReviewJACC. Basic to translational science2020

Targeting Vascular Calcification in Chronic Kidney Disease.

Adam J Nelson, Paolo Raggi, Myles Wolf, Alexander M Gold, Glenn M Chertow, Matthew T Roe

Open access · goldAbstract readReview
In one paragraph

Review in JACC. Basic to translational science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients-a systematic review and meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  18. Article
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Adam J NelsonDivision of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Paolo RaggiDivision of Cardiology, Department of Medicine, University of Alberta and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
Myles WolfDivision of Nephrology, Department of Medicine, and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Alexander M GoldResearch and Development, Sanifit Therapeutics, San Diego, California.
Glenn M ChertowDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Matthew T RoeDivision of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
Clinical Research Institute · USStanford University · USDuke University · USUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular (CV) disease remains an important cause of morbidity and mortality for patients with chronic kidney disease (CKD). Although clustering of traditional risk factors with CKD is well recognized, kidney-specific mechanisms are believed to drive the disproportionate burden of CV disease. One perturbation that is frequently observed at high rates in patients with CKD is vascular calcification, which may be a central mediator for an array of CV sequelae. This review summarizes the pathophysiological bases of intimal and medial vascular calcification in CKD, current strategies for diagnosis and management, and posits vascular calcification as a risk marker and therapeutic target.

Indexed as

CAC, coronary artery calcificationchronic kidney diseaseCI, confidence intervalCKD, chronic kidney diseaseCT, computed tomographyCV, cardiovascularCVD, cardiovascular diseasedialysiseGFR, estimated glomerular filtration rateESKD, end-stage kidney diseaseFGF, fibroblast growth factorHR, hazard ratioLDL-C, low-density lipoprotein cholesterolmedial calcificationMGP, matrix Gla proteinPTH, parathyroid hormonevascular calcificationVSMC, vascular smooth muscle cell

Identifiers

PMID32368697
PMCPMC7188874
OpenAlexW3018218533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.